SUBSCRIBE
SUBSCRIBE
News   Business

Crucell N.V. Announces PER.C6(R) Licensing Agreement With Upstate USA

May 16, 2006 | 
1 min read
Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL) announced today that it has signed a PER.C6® licensing agreement with Upstate USA, Inc., a wholly-owned subsidiary of Serologicals Corporation based in Virginia.
Alliances Europe
MORE ON THIS TOPIC
Concept of saving money with a pink colored piggy bank held in a hand in front of a blackboard with hand drawn coins
Weight loss
Novo’s CagriSema Falls to Lilly’s Zepbound in Daring Head-to-Head Test
February 23, 2026
 · 
4 min read
 · 
Annalee Armstrong
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
BMS, Catalent Further Whittle Workforces
February 23, 2026
 · 
57 min read
 · 
BioSpace Editorial Staff
Insights
Redefining Obesity Treatment Beyond GLP-1 Limits
February 19, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker
Piggy bank rocket launcher with smoke trail on blue background. Savings growth concept. 3D Rendering, 3D Illustration
Alzheimer’s disease
Korsana Joins Alzheimer’s Amyloid Arena With $150M Debut, Next-Gen Antibody
February 18, 2026
 · 
2 min read
 · 
Tristan Manalac